C Diff Foundation Hosts 3rd Annual Global C.diff. Awareness 2K Walks

TEANECK, N.J. -- C Diff Foundation announced today that registration is now open for the 3rd Annual Global C.diff. Awareness 2K Walks. The events, which will take place at the Morris A. Votee Park, Teaneck, N.J., Charlestown Township Park, Phoenixville, Pa., and Sims Park, New Port Richey, Fla., will be hosted by the C Diff Foundation on Saturday, May 18, 2019 from 8 a.m. - 12 p.m.

Dr. Martha Cloakie, PhD will be leading the walk in Leicester, U.K. on Friday, May 17, 2019.

All registered awareness walkers will receive t-shirts, giveaways, and educational material while introducing the communities to the resources available. C.diff. infections are one of the leading healthcare-associated infections facing local communities.

Registration is $20.00 per walker and children 10 years of age and under walk free. https://cdifffoundation.org/3rdannualwalk/

Proceeds from the events will benefit the C Diff Foundation's mission educating and advocating for C.difficile infection prevention, treatments, clinical trials, and environmental safety worldwide.

According to the Centers for Disease Control and Prevention (CDC), a Clostridioides difficile infection (C.difficile), (formally known as Clostridium difficile) "has become the most common microbial cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone."

Statistics provided by the CDC suggest that C. difficile cause nearly 500,000 infections in patients in the U.S. annually. In one study noted by the CDC, among infected patients, nearly 29,000 died within 30 days of being diagnosed, and more than half of those deaths (15,000) were directly attributable to a C. difficile infection.

"Every day the C Diff Foundation members work to educate and advocate for C. difficile infection prevention, treatments, clinical trials, and environmental safety while providing support worldwide. Our dedication to the cause is making a difference as we share a common goal with government agencies and health care organizations witnessing a decrease in newly diagnosed C.diff. infections and saving lives. Our dedicated volunteering members, around the globe, are focused on improving the lives of individuals and families who are impacted by C.diff. infections," says Nancy Caralla, Founding President, and Executive Director of the C Diff Foundation.

We sincerely thank Vedanta Biosciences, Inc. for being the Diamond Sponsor of the 3rd Annual Global C.diff. Awareness 2K Walks. Vedanta Biosciences, Inc. is dedicated to finding treatments for patients with serious infections and immune diseases. Vedanta develops medicines made of consortia of bacterial strains which are selected to effect robust and durable changes in a patient's gut microbiota.

In contrast to fecal transplants or administration of fecal fractions, Vedanta's medicines are pure, uniform compositions of bacteria manufactured from clonal cell banks, bypassing the need to rely on direct sourcing of fecal donor material of inconsistent composition. Vedanta is currently enrolling patients with recurrent C. difficile infections (CDI) in its CONSORTIUM study to evaluate VE303, an investigational treatment for CDI.

About the C Diff Foundation:

The C Diff Foundation, a 501(c)(3) supports public health through educating and advocating for C. difficile infection prevention, treatments, clinical trials, and environmental safety worldwide. For more information, or to find out how you can be a host of a Global C.diff. Awareness 2K Walk visit http://www.cdifffoundation.org.

Follow C Diff Foundation on Twitter
@cdiffFoundation
#CdiffWalk2019

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.